We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Halts Trial of Traumatic Bleeding Drug for Futility
Novo Nordisk Halts Trial of Traumatic Bleeding Drug for Futility
June 11, 2008
Novo Nordisk is shutting down its Phase III clinical trial of a drug to treat bleeding in patients with severe trauma after the independent data monitoring committee (DMC) said continuing it would be futile.